Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
7,182.10
6,619.75
5,634.69
5,837.83
4,229.71
3,654.66
3,475.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
7,182.10
6,619.75
5,634.69
5,837.83
4,229.71
3,654.66
3,475.05
Raw Material Cost
4,343.78
4,110.22
3,547.03
3,501.80
2,779.48
2,365.38
2,217.29
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
700.89
1,667.00
1,327.72
1,240.90
1,042.74
1,024.32
1,014.82
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
341.04
618.68
961.98
248.81
253.51
151.70
52.99
Selling and Distribution Expenses
2,213.28
2,074.67
1,132.09
916.87
773.14
830.07
768.21
Other Expenses
-104.19
-228.57
-228.97
-148.97
-129.63
-117.60
-106.78
Total Expenditure (Excl Depreciation)
6,557.07
6,184.89
4,679.12
4,418.66
3,552.61
3,195.45
2,985.50
Operating Profit (PBDIT) excl Other Income
625
434.90000000000003
955.6
1419.1999999999998
677.0999999999999
459.20000000000005
489.5
Other Income
609.19
822.12
1,267.38
292.48
285.18
280.28
173.57
Operating Profit (PBDIT)
1,624.25
1,668.66
2,565.99
2,030.38
1,274.90
984.47
895.37
Interest
341.04
618.68
961.98
248.81
253.51
151.70
52.99
Exceptional Items
0.00
0.00
0.43
7.08
0.00
19.21
0.00
Gross Profit (PBDT)
2,838.32
2,509.52
2,087.66
2,336.04
1,450.24
1,289.29
1,257.75
Depreciation
390.03
411.68
343.04
318.73
312.62
244.98
232.25
Profit Before Tax
893.18
638.29
1,261.40
1,469.91
708.77
607.00
610.13
Tax
519.46
515.28
621.37
223.60
-150.90
174.79
243.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
265.67
31.55
555.12
1,184.70
822.16
433.11
366.51
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
265.67
31.55
555.12
1,184.70
822.16
433.11
366.51
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
108.06
91.46
84.91
61.62
37.51
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
373.73
123.01
640.03
1,246.32
859.67
433.11
366.51
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,473.58
6,191.61
5,981.56
5,146.21
4,594.34
4,056.60
3,596.44
Earnings per share (EPS)
0.5
0.06
1.05
2.24
1.56
0.82
0.69
Diluted Earnings per share
0.5
0.06
1.05
2.24
1.56
0.82
0.69
Operating Profit Margin (Excl OI)
8.7%
6.57%
16.96%
24.31%
16.01%
12.57%
14.09%
Gross Profit Margin
17.87%
15.86%
28.47%
30.64%
24.15%
23.31%
24.24%
PAT Margin
3.7%
0.48%
9.85%
20.29%
19.44%
11.85%
10.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 8.50% vs 17.48% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 203.82% vs -80.78% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 19.92% vs -34.81% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -44.88% vs -35.69% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Asiri Surgical Hospital Plc With
Figures in Million
Consolidate Annual Results
Change(LKR)
Change(%)
Net Sales
7,182.10
13,650.11
-6,468.01
-47.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
7,182.10
13,650.11
-6,468.01
-47.38%
Raw Material Cost
4,343.78
8,015.19
-3,671.41
-45.81%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
700.89
3,449.68
-2,748.79
-79.68%
Power Cost
0
0
0.00
Manufacturing Expenses
341.04
57.94
283.10
488.61%
Selling and Distribution Expenses
2,213.28
2,757.81
-544.53
-19.75%
Other Expenses
-104.19
-350.76
246.57
70.30%
Total Expenditure (Excl Depreciation)
6,557.07
10,773.01
-4,215.94
-39.13%
Operating Profit (PBDIT) excl Other Income
625.03
2,877.10
-2,252.07
-78.28%
Other Income
609.19
-923.83
1,533.02
165.94%
Operating Profit (PBDIT)
1,624.25
2,716.68
-1,092.43
-40.21%
Interest
341.04
57.94
283.10
488.61%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,838.32
5,634.91
-2,796.59
-49.63%
Depreciation
390.03
763.42
-373.39
-48.91%
Profit Before Tax
893.18
1,895.32
-1,002.14
-52.87%
Tax
519.46
555.89
-36.43
-6.55%
Provisions and contingencies
0
0
0.00
Profit After Tax
265.67
1,339.43
-1,073.76
-80.17%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
265.67
1,339.43
-1,073.76
-80.17%
Share in Profit of Associates
0
0
0.00
Minority Interest
108.06
0.00
108.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
373.73
1,339.43
-965.70
-72.10%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,473.58
14,178.40
-7,704.82
-54.34%
Earnings per share (EPS)
0.50
5.99
-5.49
-91.65%
Diluted Earnings per share
0.50
5.99
-5.49
-91.65%
Operating Profit Margin (Excl OI)
8.70%
21.08%
0.00
-12.38%
Gross Profit Margin
17.87%
19.48%
0.00
-1.61%
PAT Margin
3.70%
9.81%
0.00
-6.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 718.21 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 8.50% vs 17.48% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 37.37 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 203.82% vs -80.78% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 101.51 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 19.92% vs -34.81% in Mar 2024
Annual - Interest
Interest 34.10 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -44.88% vs -35.69% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.70%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024






